Rezvoglar Injection, Solution
Product Images NDC 0002-8980

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Rezvoglar (NDC 0002-8980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rezvoglar Uspi F1)

A line graph depicting glucose infusion rate (mg/kg/min) over time (hours) after subcutaneous injection, comparing Insulin glargine and NPH insulin with data from 20 subjects each. The graph shows glucose infusion rates on the y-axis and time up to 30 hours on the x-axis, with a marker indicating the end of the observation period.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 0 V1)

An anatomical illustration showing injection sites on a human body for subcutaneous administration. Highlighted areas include the upper arms, stomach, and thighs as appropriate locations for injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 1 V2)

An illustration diagram of the Rezvoglar KwikPen, a subcutaneous injection pen for insulin glargine-aglr 100 units/mL. The diagram labels the pen's parts including the pen cap with cap clip, rubber seal, cartridge holder, plunger, pen body with label, dose indicator featuring the dose window, and dose knob.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 2 V1)

An instructional illustration showing the parts of a pen needle including the outer needle shield, inner needle shield, paper tab, and needle, along with a depiction of a dose knob featuring a green ring. The pen needle is labeled as not included.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 3 V1)

An instructional diagram showing how to remove a cap from a pen injection device by twisting and pulling the cap off the pen tip.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 4 V1)

An instructional illustration showing a close-up of a Rezvoglar KwikPen dose selector window, with a red arrow pointing upward toward the pen's dose knob, indicating the step to adjust or set the insulin dose for injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 5 V2)

An instructional illustration showing the disposal step of a medical device, indicated by an arrow pointing left and a highlighted message reading 'Throw Away' below the device's tip, emphasizing proper disposal after use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 6 V1)

An instructional illustration showing a hand holding a Rezvoglar KwikPen injection device. The image emphasizes pressing a button at the bottom of the pen with an upward arrow, with a zoomed-in view of the needle tip extending from the pen, indicating the injection mechanism for subcutaneous use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 7 V1)

An illustration showing a close-up view of the dose selector window on a Rezvoglar KwikPen insulin injection device. The image highlights the dose indicator scale with a red marker near the zero dose line, indicating a dialed dose setting, and the pen's grip area with indentation details for finger placement.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 8 V1)

An instructional illustration showing a close-up view of a hand holding part of a Rezvoglar KwikPen insulin injection device. The illustration depicts an upward arrow indicating the action of pulling or sliding a component from the pen, likely related to preparing or priming the injection device before use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 9 V1)

An instructional diagram showing a close-up of a device window with a dose indicator displaying the number 12, and an arrow pointing to it, likely illustrating how to read the dose setting on the injection device.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 10 V1)

An illustration showing a close-up of the dose selector window on a device, likely an insulin pen, displaying dose levels ranging from 2 to 26 units in increments of 2. A red arrow points specifically at the dose level 24, highlighting dose selection on the pen's dial.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 11 V2)

An instructional illustration showing the use of the Rezvoglar KwikPen insulin injection. It depicts a person holding the KwikPen and preparing to inject it subcutaneously into the abdominal area just above the waistline, indicating proper injection technique and positioning.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 12 V1)

An instructional illustration showing a hand holding a Rezvoglar KwikPen insulin injection pen and wrapping the pen with a red ribbon or band, likely demonstrating proper handling or preparation of the device for subcutaneous injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 13 V1)

Rezvoglar KwikPen injection pen containing insulin glargine-aglr 100 units per mL (U-100). The white, pen-shaped device displays the product name and strength on a beige label near the dial, with a dosing window showing numeric dose increments. The device is designed for subcutaneous injection and single patient use. Labeler is Eli Lilly and Company.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 14 V1)

Rezvoglar KwikPen injection, solution in a prefilled pen device for subcutaneous use. The pen is white with a dosage window showing dose increments, and a label section with printed lot and expiration information. The product is manufactured by Eli Lilly and Company.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 15 V1)

An instructional diagram showing the proper removal of a needle from a pen device, likely for the Rezvoglar KwikPen insulin glargine-aglr injection. The image displays the pen with a needle attached and an arrow pointing left, indicating the direction to pull the needle off from the pen.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 16 V1)

Illustration of a Rezvoglar KwikPen insulin injection device. The diagram shows the pen with a dose window and a numbered scale, designed for subcutaneous administration of insulin glargine-aglr 100 units/mL solution by Eli Lilly and Company.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 17 V1)

Instructional illustration depicting a hand holding an insulin vial or pen while the other hand peels or removes a protective foil seal from the vial or pen tip, related to preparing an insulin injection, such as Rezvoglar KwikPen (insulin glargine-aglr) injection solution.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 18 V1)

An instructional diagram showing a hand twisting and removing a protective cap from the top of a pen device. A red curved arrow indicates the direction to turn the cap to remove it.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 19 V1)

Instructional illustration showing a syringe needle cap with the word 'Keep' next to it and an arrow pointing left. The image is part of a procedural diagram likely related to the preparation or handling of an injection product.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 22 V1)

An instructional diagram showing a stopwatch icon indicating a 5-second duration, likely representing a recommended wait or action time related to the use of the product Rezvoglar KwikPen insulin injection.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 23 V1)

An instructional illustration showing a person administering a subcutaneous injection into the abdominal area using a pen-style injector. The person uses one hand to pinch the skin and the other to hold and inject the pen device.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 24 V1)

An instructional illustration showing a hand removing the cap from a vial marked with a biohazard symbol. The image appears to demonstrate a step in preparing a medication or biological solution for use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 25 V1)

An instructional diagram showing how to remove the cap from the Rezvoglar KwikPen insulin injection pen by pulling it straight off, indicated by a right-pointing red arrow.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 26 V1)

An instructional illustration showing a hand removing the protective cap from the needle of a Rezvoglar KwikPen injection device. The diagram highlights the first step in preparing the insulin glargine-aglr 100 IU/mL subcutaneous injection pen for use.*

FDA Label Image

Figure (Rezvoglar Kpen 80u Ifu 27 V1)

An illustration showing an assembled Rezvoglar KwikPen insulin injection device, highlighting the needle tip on one end and the dose window on the other end. The pen body label displays the product name Rezvoglar KwikPen and its concentration of 100 units per mL for subcutaneous injection.*

FDA Label Image

Package Carton – Rezvoglar Kwikpen Carton (Rezvoglar Kpen 80u Cart 064 01)

Packaging label for Rezvoglar KwikPen (insulin glargine-aglr) injection 100 units per mL (U-100) by Eli Lilly and Company. The label displays 5 prefilled 3 mL pens intended for subcutaneous use only, dosage instructions, storage warnings, and manufacturer information, including a barcode and NDC 0002-8980-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.